Literature DB >> 5673195

Reduced incidence of spontaneous metastases with long-term Coumadin therapy.

J J Ryan, A S Ketcham, H Wexler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5673195      PMCID： PMC1387203          DOI： 10.1097/00000658-196807000-00021

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  7 in total

1.  CANCER INCIDENCE AND MORTALITY IN PATIENTS HAVING ANTICOAGULANT THERAPY.

Authors:  L MICHAELS
Journal:  Lancet       Date:  1964-10-17       Impact factor: 79.321

2.  THE EFFECTS OF FIBRIN FORMATION AND ALTERATIONS IN THE CLOTTING MECHANISM ON THE DEVELOPMENT OF METASTASES.

Authors:  E E CLIFFTON; D AGOSTINO
Journal:  Vasc Dis       Date:  1965-01

3.  The time of metastasis and release of circulating tumor cells as determined in an experimental system.

Authors:  M D ROMSDAHL; E W CHU; R HUME; R R SMITH
Journal:  Cancer       Date:  1961 Jul-Aug       Impact factor: 6.860

4.  Pathogenesis of metastasis formation observed in vivo in the rabbit ear chamber.

Authors:  S WOOD
Journal:  AMA Arch Pathol       Date:  1958-10

5.  Accurate identification of experimental pulmonary metastases.

Authors:  H Wexler
Journal:  J Natl Cancer Inst       Date:  1966-04       Impact factor: 13.506

Review 6.  Experimental study of metastases.

Authors:  A S Ketcham; H Wexler; J P Minton
Journal:  JAMA       Date:  1966-10-10       Impact factor: 56.272

7.  Effect of prolonged coumadin treatment on the production of pulmonary metastases in the rat.

Authors:  D Agostino; E E Cliffton; A Girolami
Journal:  Cancer       Date:  1966-02       Impact factor: 6.860
  7 in total
  9 in total

1.  Aspirin for reducing cancer metastases?

Authors:  U K Henschke; G J Luande; J D Choppala
Journal:  J Natl Med Assoc       Date:  1977-08       Impact factor: 1.798

Review 2.  Gastrointestinal Bleeding on Oral Anticoagulation: What is Currently Known.

Authors:  Arnar B Ingason; Johann P Hreinsson; Einar S Björnsson
Journal:  Drug Saf       Date:  2022-10-13       Impact factor: 5.228

3.  Association of Warfarin Use With Lower Overall Cancer Incidence Among Patients Older Than 50 Years.

Authors:  Gry S Haaland; Ragnhild S Falk; Oddbjørn Straume; James B Lorens
Journal:  JAMA Intern Med       Date:  2017-12-01       Impact factor: 21.873

Review 4.  [The significance of fibrin/fibrinogen for growth and metastasis of malignant tumors (author's transl)].

Authors:  H Heyes; D Glück
Journal:  Klin Wochenschr       Date:  1977-11-15

5.  Anticoagulants and experimental metastases-evaluation of antimetastatic effects in different model systems.

Authors:  B Maat; P Hilgard
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

Review 6.  The Role of TAM Family Receptors in Immune Cell Function: Implications for Cancer Therapy.

Authors:  Magdalena Paolino; Josef M Penninger
Journal:  Cancers (Basel)       Date:  2016-10-21       Impact factor: 6.639

7.  The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells.

Authors:  Magdalena Paolino; Axel Choidas; Stephanie Wallner; Blanka Pranjic; Iris Uribesalgo; Stefanie Loeser; Amanda M Jamieson; Wallace Y Langdon; Fumiyo Ikeda; Juan Pablo Fededa; Shane J Cronin; Roberto Nitsch; Carsten Schultz-Fademrecht; Jan Eickhoff; Sascha Menninger; Anke Unger; Robert Torka; Thomas Gruber; Reinhard Hinterleitner; Gottfried Baier; Dominik Wolf; Axel Ullrich; Bert M Klebl; Josef M Penninger
Journal:  Nature       Date:  2014-02-19       Impact factor: 49.962

8.  Enhancement of pulmonary tumour seeding by human coagulation factors II, IX, X--an investigation into the possible mechanisms involved.

Authors:  A D Purushotham; P McCulloch; W D George
Journal:  Br J Cancer       Date:  1991-09       Impact factor: 7.640

9.  Effects of anticoagulation and ileal resection on the development and spread of experimental intestinal carcinomas.

Authors:  R C Williamson; P J Lyndon; A J Tudway
Journal:  Br J Cancer       Date:  1980-07       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.